165 related articles for article (PubMed ID: 25925418)
1. The role of histone demethylase KDM4B in Myc signaling in neuroblastoma.
Yang J; AlTahan AM; Hu D; Wang Y; Cheng PH; Morton CL; Qu C; Nathwani AC; Shohet JM; Fotsis T; Koster J; Versteeg R; Okada H; Harris AL; Davidoff AM
J Natl Cancer Inst; 2015 Jun; 107(6):djv080. PubMed ID: 25925418
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability.
Wang Z; Cai H; Li Z; Sun W; Zhao E; Cui H
Clin Epigenetics; 2023 Dec; 15(1):192. PubMed ID: 38093312
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of histone lysine demethylase KDM4B blocks the growth of castration-resistant prostate cancer.
Duan L; Chen YA; Liang Y; Chen Z; Lu J; Fang Y; Cao J; Lu J; Zhao H; Pong RC; Hernandez E; Kapur P; Tran TAT; Smith T; Martinez ED; Ahn JM; Hsieh JT; Luo JH; Liu ZP
Biomed Pharmacother; 2023 Feb; 158():114077. PubMed ID: 36495660
[TBL] [Abstract][Full Text] [Related]
4. KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels.
Choi JY; Yoon SS; Kim SE; Ahn Jo S
Sci Rep; 2017 Mar; 7():45005. PubMed ID: 28327608
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Regulation of NGF-Mediated Osteogenic Differentiation in Human Dental Mesenchymal Stem Cells.
Liu Z; Suh JS; Deng P; Bezouglaia O; Do M; Mirnia M; Cui ZK; Lee M; Aghaloo T; Wang CY; Hong C
Stem Cells; 2022 Sep; 40(9):818-830. PubMed ID: 35728620
[TBL] [Abstract][Full Text] [Related]
6. Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.
Abu-Zaid A; Fang J; Jin H; Singh S; Pichavaram P; Wu Q; Tillman H; Janke L; Rosikiewicz W; Xu B; Van De Velde LA; Guo Y; Li Y; Shendy NAM; Delahunty IM; Rankovic Z; Chen T; Chen X; Freeman KW; Hatley ME; Durbin AD; Murray PJ; Murphy AJ; Thomas PG; Davidoff AM; Yang J
Cell Rep Med; 2024 Mar; 5(3):101468. PubMed ID: 38508144
[TBL] [Abstract][Full Text] [Related]
7. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
[TBL] [Abstract][Full Text] [Related]
8. KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner.
Wang XY; Li HM; Xia R; Li X; Zhang X; Jin TZ; Zhang HS
Mol Cell Biochem; 2024 Apr; 479(4):915-928. PubMed ID: 37249813
[TBL] [Abstract][Full Text] [Related]
9. [The Regulatory Effect of RNA m
Li YQ; Shao YL; Li MY; Wang LL; Gao XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):382-388. PubMed ID: 38660840
[TBL] [Abstract][Full Text] [Related]
10. KDM4B: A promising oncology therapeutic target.
Ni F; Tang H; Cheng S; Yu Y; Yuan Z; Chen Y; Zhang E; Wang X
Cancer Sci; 2024 Jan; 115(1):8-16. PubMed ID: 37923555
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor c-Fos coordinates with histone lysine-specific demethylase 2A to activate the expression of cyclooxygenase-2.
Lu S; Yang Y; Du Y; Cao LL; Li M; Shen C; Hou T; Zhao Y; Wang H; Deng D; Wang L; He Q; Zhu WG
Oncotarget; 2015 Oct; 6(33):34704-17. PubMed ID: 26430963
[TBL] [Abstract][Full Text] [Related]
12. Targeting c-Myc transactivation by LMNA inhibits tRNA processing essential for malate-aspartate shuttle and tumour progression.
Wang J; Hong M; Cheng Y; Wang X; Li D; Chen G; Bao B; Song J; Du X; Yang C; Zheng L; Tong Q
Clin Transl Med; 2024 May; 14(5):e1680. PubMed ID: 38769668
[TBL] [Abstract][Full Text] [Related]
13. Human phenotype caused by biallelic KDM4B frameshift variant.
Takada S; Silva S; Zamorano I; Pérez A; Iwabuchi C; Miyake N
Clin Genet; 2024 Jan; 105(1):72-76. PubMed ID: 37526414
[TBL] [Abstract][Full Text] [Related]
14. Mitotic gene regulation by the N-MYC-WDR5-PDPK1 nexus.
Streeter SA; Williams AG; Evans JR; Wang J; Guarnaccia AD; Florian AC; Al-Tobasei R; Liu Q; Tansey WP; Weissmiller AM
BMC Genomics; 2024 Apr; 25(1):360. PubMed ID: 38605297
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor.
Jablonowski CM; Quarni W; Singh S; Tan H; Bostanthirige DH; Jin H; Fang J; Chang TC; Finkelstein D; Cho JH; Hu D; Pagala V; Sakurada SM; Pruett-Miller SM; Wang R; Murphy A; Freeman K; Peng J; Davidoff AM; Wu G; Yang J
Elife; 2024 Mar; 12():. PubMed ID: 38488852
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlation study of structural abnormalities in a fetal brain caused by a novel KDM4B variant.
Zhao X; Li X; Yu M; Jia JA; Tian R; Zhu F
Mol Biol Rep; 2024 Jan; 51(1):188. PubMed ID: 38270710
[TBL] [Abstract][Full Text] [Related]
17. USP44 overexpression drives a MYC-like gene expression program in neuroblastoma through epigenetic reprogramming.
Ekstrom TL; Hussain S; Bedekovics T; Ali A; Paolini L; Mahmood H; Rosok RM; Koster J; Johnsen SA; Galardy PJ
Mol Cancer Res; 2024 May; ():. PubMed ID: 38775808
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase UCHL1 stabilizes KDM4B to augment VEGF signaling and confer bevacizumab resistance in clear cell renal cell carcinoma.
Cheng J; Liu H; Shen Y; Ding J; He H; Mao S; Chen L; Zhang C; Zhou J
Transl Oncol; 2024 Jul; 45():101987. PubMed ID: 38743986
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of c-MYC gene expression in hematological malignancies.
Okafor IM; Okoroiwu HU; Ogar CO
Afr Health Sci; 2023 Jun; 23(2):265-273. PubMed ID: 38223598
[TBL] [Abstract][Full Text] [Related]
20. JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells.
Kuo YT; Liu YL; Adebayo BO; Shih PH; Lee WH; Wang LS; Liao YF; Hsu WM; Yeh CT; Lin CM
PLoS One; 2015; 10(5):e0125343. PubMed ID: 25951238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
